These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9744355)

  • 1. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability.
    Bhatnagar A; Vezza PR; Bryan JA; Atkins FB; Ziessman HA
    J Nucl Med; 1998 Sep; 39(9):1617-20. PubMed ID: 9744355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.
    Jorna FH; Hollema H; Hendrikse HN; Bart J; Brouwers AH; Plukker JT
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):406-12. PubMed ID: 19235131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism.
    Gupta Y; Ahmed R; Happerfield L; Pinder SE; Balan KK; Wishart GC
    Br J Surg; 2007 Dec; 94(12):1491-5. PubMed ID: 17929232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake.
    Akin M; Atasever T; Kurukahvecioglu O; Dogan M; Gokaslan D; Poyraz A; Koksal H; Taneri F
    Bratisl Lek Listy; 2009; 110(3):166-9. PubMed ID: 19507637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sestamibi scan as a preoperative screening tool.
    Norton KS; Johnson LW; Griffen FD; Burke J; Kennedy S; Aultman D; Li BD; Zibari G
    Am Surg; 2002 Sep; 68(9):812-5. PubMed ID: 12356156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
    Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
    Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
    Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and
    Kushchayeva YS; Tella SH; Kushchayev SV; Van Nostrand D; Kulkarni K
    Osteoporos Int; 2019 May; 30(5):1051-1057. PubMed ID: 30706095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
    Gordon L; Burkhalter W; Mah E
    J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue.
    Mehta NY; Ruda JM; Kapadia S; Boyer PJ; Hollenbeak CS; Stack BC
    Arch Otolaryngol Head Neck Surg; 2005 Jun; 131(6):493-8. PubMed ID: 15967881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT; Rimkus DR; Hartzman S; Latimer RG
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content.
    Carpentier A; Jeannotte S; Verreault J; Lefebvre B; Bisson G; Mongeau CJ; Maheux P
    J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings.
    Merlino JI; Ko K; Minotti A; McHenry CR
    Am Surg; 2003 Mar; 69(3):225-9; discussion 229-30. PubMed ID: 12678479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid scintigraphy with iodine-123 and 99mTc-sestamibi: imaging findings.
    Burke GJ; Wei JP; Binet EF
    AJR Am J Roentgenol; 1993 Dec; 161(6):1265-8. PubMed ID: 8249740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging.
    Takeuchi H; Greep NC; Hoon DS; Giuliano AE; Hansen NM; Umetani N; Singer FR
    J Clin Endocrinol Metab; 2007 May; 92(5):1785-90. PubMed ID: 17299072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
    O'Doherty MJ; Kettle AG; Wells P; Collins RE; Coakley AJ
    J Nucl Med; 1992 Mar; 33(3):313-8. PubMed ID: 1531500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [False negative spect parathyroid scintigraphy with sestamibi in patients with primary hyperparathyroidism].
    Paillahueque G; Massardo T; Barberán M; Ocares G; Gallegos I; Toro L; Araya AV
    Rev Med Chil; 2017 Aug; 145(8):1021-1027. PubMed ID: 29189860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.